Japanese startup Celaid Therapeutics completes second close of Series B financing round with $2.6 M

Japanese startup Celaid Therapeutics Inc. has announced the completion of the second close of its Series B financing rou...

October 5, 2026 | Monday | News
PRECISE and Temus establish Joint Innovation Centre to advance precision health in Singapore

Precision Health Research, Singapore (PRECISE), and AI & digital transformation company, Temus, have signed a memora...

October 3, 2026 | Saturday | News
Quantum sensing device secures $2.2M funding boost to improve iron diagnosis in Australia

New quantum sensing technology that could transform clinical iron testing has received a major funding boost of $2.2 mil...

October 3, 2026 | Saturday | News
AABB expands biotherapies coverage with special TRANSFUSION journal supplement

The Association for the Advancement of Blood & Biotherapies (AABB) has published a special supplemental issue of its...

October 1, 2026 | Thursday | News
Toho, Reprocell partner for domestic distribution of regenerative medical product Stemchymal® in Japan

Reprocell Inc. has entered into a basic agreement with Toho Holdings toward a partnership concerning the domestic distri...

October 3, 2026 | Saturday | News
Singapore designs electronic skin combining sensing and visualisation in single device

Researchers from the National University of Singapore (NUS) have developed a next-generation electronic skin that can bo...

September 29, 2026 | Tuesday | News
Singapore named GA4GH’s Asia-Pacific anchor for global genomics

Singapore is hosting the Global Alliance for Genomics and Health (GA4GH) 14th Plenary meeting from 28 September to 2 Oct...

September 29, 2026 | Tuesday | News
European Commission grants marketing authorisation for NEZGLYAL, first pharmacological treatment for cALD

Neuraxpharm Group and Minoryx Therapeutics have announced that the European Commission has granted marketing authorisati...

September 28, 2026 | Monday | News
Deep Origin deploys AI-powered ADMET models across drug discovery programmes

Deep Origin and partners in the Pharmacological Research and Evaluation through Digital Integration and Clinical Trials ...

September 28, 2026 | Monday | News
APEC’s Opportunity to Lead: Transforming Lung Cancer Outcomes Across Asia Pacific

As Asia Pacific economies grapple with ageing populations, shrinking workforces and rising healthcare expenditure, they ...

September 28, 2026 | Monday | News
China's InnoCare inks $3.5 B deal with Eli Lilly to develop new medicines

InnoCare Pharma, a China-based biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, ha...

September 28, 2026 | Monday | News
Japan Agency for Medical Research and Development provides ¥2.8 B grant to United Immunity

United Immunity, a clinical stage biotechnology company, has raised a total of ¥2.2 billion in private financing, co...

September 28, 2026 | Monday | News
From Microbiome to Mind: APAC's Push to Make the Gut-Brain Axis Clinically Actionable

Researchers are now increasingly examining mental health as the product of interactions among the nervous, immune, metab...

October 1, 2026 | Thursday | Opinion
mRNA’s Cancer Breakthrough

The success of mRNA vaccines during the COVID-19 pandemic transformed the technology from a promising scientific approac...

October 1, 2026 | Thursday | Analysis
Korea's Seoul National University Hospital joins hands with Cellares for automated manufacturing of Gene-Modified HSPC therapy

Cellares, US-based Integrated Development and Manufacturing Organisation (IDMO), and Seoul National University Hospital ...

September 25, 2026 | Friday | News
NUS Enterprise evolves into NUSX to expand global pathways for deep tech ventures

NUS Enterprise, the entrepreneurial heart of the National University of Singapore, has unveiled its next chapter as NUSX...

September 24, 2026 | Thursday | News
Melbourne joins global consortium to advance drug discovery

The University of Melbourne has joined the Structural Genomics Consortium (SGC) with the establishment of SGC-Melbourne,...

September 24, 2026 | Thursday | News
Bio-Techne opens new Customer Experience Center in Düsseldorf to accelerate scientific discovery

Bio-Techne Corporation, a global provider of life science tools, reagents and diagnostic products, today announced the o...

September 23, 2026 | Wednesday | News
Researchers in Taiwan call for better drug delivery strategies for ageing brain

Researchers from Birla Institute of Technology and Science, Pilani (BITS Pilani), India and institutions in Taiwan have ...

September 23, 2026 | Wednesday | News
University of Sydney launches Australia's new ace against cancer

An Australian-first cancer research facility that will allow scientists to examine individual cancer and immune cells in...

September 23, 2026 | Wednesday | News
“The future is about personalised medicine, targeted therapies, immunotherapy, and increasingly precise drug delivery working together”

The latest personalised mRNA cancer vaccine data have renewed attention on individualized oncology. How significant is t...

September 22, 2026 | Tuesday | Opinion
As Asia Advances, Purification Must Keep Pace to Deliver Certainty in an Uncertain World

  As Asia-Pacific’s manufacturing landscape becomes more sophisticated, purification and separation technolo...

September 22, 2026 | Tuesday | Influencers
Korea's 1ST Biotherapeutics and SK Biopharma announce partnership for Parkinson's treatment

South Korea-based 1ST Biotherapeutics, Inc. and SK Biopharmaceuticals have entered into an exclusive global li...

September 22, 2026 | Tuesday | News
National Taiwan University Hospital inks MoU with Johnson & Johnson

To further enhance Taiwan’s role in global clinical research and innovative drug development, accelerate the advan...

September 22, 2026 | Tuesday | News
Korea's NAVER D2SF invests in AI-driven precision medicine company ImpriMed

South Korea-based NAVER D2SF, NAVER's inhouse corporate venture arm, has invested in ImpriMed, a Silicon Valley-based pr...

September 21, 2026 | Monday | News